Publication | Open Access

Structure–activity relationship study of BACE1 inhibitors possessing a chelidonic or 2,6-pyridinedicarboxylic scaffold at the P2 position

Molecular PharmacologyMedicinal ChemistryBiochemistryBace1 InhibitorsStructure–activity Relationship StudyNatural SciencesMedicineRational Drug DesignMechanism Of ActionAnti-cancer AgentP2 PositionChemical BiologyPharmacologyMolecular ModelingPharmaceutical ChemistryInhibitory ActivityDrug Discovery